Ganglioside GD1a Antibody (IgG), EIA
Test Code
38916
83520
Clinical Significance
Ganglioside GD1a Antibody (IgG), EIA - Ganglioside GD1a antibody IgG is associated with acute motor axonal neuropathy, sometimes followed by Campylobacter jejuni infections. Ganglioside GD1a antibody IgG can aid in the diagnosis of acute motor axonal neuropathy variant of Guillain-Barre syndrome.
Test Resources
None found for this test
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
Overnite fasting is preferred
Methodology
Enzyme Immunoassay (EIA)
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Reference Range(s)
<1:100 titer
Preferred Specimen(s)
1 mL serum
Minimum Volume
0.2 mL
Transport Container
Transport tube
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
- Room temperature: 24 hours
- Refrigerated: 7 days
- Frozen: 30 Days
Reject Criteria
Received room temperature
Setup Schedule
1 mL serum
0.2 mL
Transport tube
Refrigerated (cold packs)
Room temperature: 24 hours
Refrigerated: 7 days
Frozen: 30 Days
Refrigerated: 7 days
Frozen: 30 Days
Received room temperature